Status:

COMPLETED

World Maternal Antifibrinolytic Trial

Lead Sponsor:

London School of Hygiene and Tropical Medicine

Conditions:

Postpartum Haemorrhage

Eligibility:

FEMALE

16+ years

Phase:

PHASE3

Brief Summary

The WOMAN trial is a large pragmatic randomised double-blind, placebo controlled trial to quantify the effects of the early administration of tranexamic acid on death, hysterectomy and other relevant ...

Detailed Description

BACKGROUND: Each year, worldwide about 530,000 women die from causes related to pregnancy and childbirth. Almost all (99%) of the deaths are in low and middle income countries. Obstetric haemorrhage i...

Eligibility Criteria

Inclusion

  • All legally adult women with postpartum haemorrhage following vaginal or caesarean section delivery who have a clinical diagnosis of postpartum haemorrhage. The clinical diagnosis of PPH may be based on any of the following:
  • Blood loss after vaginal delivery \> 500 mL OR
  • \> 1,000 mL after caesarean section OR blood loss sufficient to compromise the haemodynamic status of the woman The fundamental eligibility criterion is the responsible clinician's 'uncertainty' as to whether or not to use an antifibrinolytic agent in a particular woman with postpartum haemorrhage.
  • Women for whom the responsible doctor considers there is a clear indication for antifibrinolytic therapy should not be randomised.
  • Women for whom there is considered to be a clear contraindication to antifibrinolytic therapy should not be randomised.
  • Where the responsible clinician is substantially uncertain as to whether or not to use an antifibrinolytic, all these women are eligible for randomisation and should be considered for the trial.
  • There are no other pre-specified exclusion criteria.

Exclusion

    Key Trial Info

    Start Date :

    May 1 2009

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    April 1 2017

    Estimated Enrollment :

    20060 Patients enrolled

    Trial Details

    Trial ID

    NCT00872469

    Start Date

    May 1 2009

    End Date

    April 1 2017

    Last Update

    February 26 2018

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University College Hospital

    Ibadan, Nigeria